Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
Abstract
Gene expression studies conducted with mouse models of Huntington's disease (HD) have revealed profound modifications in gene transcription. However, the complexity of in vivo tissue hampers definition of very early transcriptional modifications and does not allow discrimination between cell-autonomous changes and those resulting from intercellular activity processes. To identify early, cell-autonomous transcriptional changes, we compared gene expression profiles of clonal striata-derived cells expressing different N-terminal 548-amino-acid huntingtin fragments (with 26, 67, 105 or 118 glutamines) under the control of a doxycycline-regulated promoter. In these cells, mutant huntingtin did not form aggregates or cause cell death; therefore, the gene expression profiles report transcriptional changes reflecting early pathogenic events. We found that genes involved in cell signaling, transcription, lipid metabolism and vesicle trafficking were affected, in some cases, within 12 hours of mutant protein induction. Interestingly, this study revealed differential expression of a number of genes involved in cholesterol and fatty acid metabolism, suggesting that these metabolic pathways may play a role in HD pathogenesis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
It has been demonstrated in vitro that mutant huntingtin represses genes involved in cholesterol metabolism possibly due to a lower transcriptional activity of SREBP2.
“It has been demonstrated in vitro that mutant HTT represses genes involved in cholesterol metabolism [50] possibly due to a lower transcriptional activity of the Sterol Regulatory Element Binding Protein 2 (SREBP2).”
From Loss of Mevalonate/Cholesterol Homeostasis in the Brain: A Focus on Autism Spectrum Disorder and Rett Syndrome (2019) · cites this paper as [50]
Cited by
Sorted by citations
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · see citing works
The Energetics of Huntington's Disease
Browne, S. E., & Beal, M. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014824.04728.dd · Cited by 240 · see citing works
Huntington's disease: The current state of research with peripheral tissues
Sassone, J., Colciago, C., Cislaghi, G., Silani, V., & Ciammola, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.012 · Cited by 175 · see citing works
Altered cholesterol and fatty acid metabolism in Huntington disease
Block, R. C., Dorsey, E. R., Beck, C. A., Brenna, J. T., & Shoulson, I. (2010) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2009.11.003 · Cited by 152 · see citing works
Kreilaus, F., Spiro, A. S., McLean, C. A., Garner, B., & Jenner, A. M. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12286 · Cited by 92 · see citing works
Segatto, M., Tonini, C., Pfrieger, F. W., Trezza, V., & Pallottini, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133317 · Cited by 51 · see citing works
Expression profiling of drug response - from genes to pathways
Herwig, R., & Lehrach, H. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/rherwig · Cited by 14 · see citing works
Technology Insight: querying the genome with microarrays—progress and hope for neurological disease
Coppola, G., & Geschwind, D. H. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0133 · Cited by 12 · see citing works
- Authors
- Sipione, S.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Sipione, S.
- ORCID
- Sipione, S.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-15
- Volume
- 11
- Issue
- 17
- Pages
- 1953-1965
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W4235071471
- Cited by
- 209
- References
- 0
- Citations by year
- 2026: 5 · 2025: 5 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 12 · 2018: 3 · 2017: 2 · 2016: 11 · 2015: 11 · 2014: 7 · 2013: 5 · 2012: 8
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Iris (University of Trento) (submittedVersion)
- Funders
- Hereditary Disease Foundation
- National Institute of Neurological Disorders and Stroke (NS42157, R01NS042157)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Keywords
- Huntington's disease, mutant huntingtin, striatal cells, gene expression profiling, gene expression changes, cell-autonomous effects, doxycycline-inducible expression, cholesterol metabolism, fatty acid metabolism, lipid metabolism, vesicle trafficking, signal transduction, early pathogenesis
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Cholesterol, Corpus Striatum, Fatty Acids, Gene Expression Regulation, Humans, Huntington Disease, Immunoenzyme Techniques, Molecular Sequence Data, Mutation, Peptides, RNA, Messenger, Blotting, Northern, Trinucleotide Repeat Expansion, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review